Response to Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency

Published:2024-08-21 Issue: Volume: Page:
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Boscoe Audra¹,McCracken Rebecca²,Marathe Punit³,Osman Kareem⁴

Affiliation:

1. VP, HEOR & Data Science Analytics, Agios Pharmaceuticals, Inc., Cambridge, MA

2. Global Scientific Communications & Publications, Agios Pharmaceuticals, Inc., Cambridge, MA

3. VP, Research and DMPK, Agios Pharmaceuticals, Inc., Cambridge, MA

4. VP, Clinical Development, Agios Pharmaceuticals, Inc., Cambridge, MA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Mitapivat: a Quinolone Sulfonamide to manage hemolytic anemia in adults with pyruvate kinase deficiency;Wills;Am J Ther.,2023

2. Safety and efficacy of mitapivat in pyruvate kinase deficiency;Grace;N Engl J Med.,2019

3. Mitapivat versus placebo for pyruvate kinase deficiency;Al-Samkari;N Engl J Med.,2022

4. Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (activate-T): a multicentre, openlabel, single-arm, phase 3 trial;Glenthøj;Lancet Haematol.,2022

5. Mitapivat (AG-348) demonstrates safety, tolerability, and improvements in anemia, hemolysis, oxygen affinity, and hemoglobin S polymerization kinetics in adults with sickle cell disease: a phase 1 dose escalation study;Xu;Blood,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP